![](https://endpts.com/wp-content/uploads/2021/03/John-Chiminski-Catalent-tile-JPM20-scaled.jpg)
John Chiminski at JPM20 (Jeff Rumans)
Catalent amps up plans to manufacture J&J's Covid-19 vaccine, adding vial filling line in Italy
A little more than a year after Catalent CEO John Chiminski acquired Bristol Myers Squibb’s manufacturing facility in Anagni, Italy, the big CDMO is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.